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Abstract
Background: Using a mobile app for self-management could make it easier for patients to get insight into their blood pressure
patterns. However, little is known about the availability, quality, and features of mobile apps targeting blood pressure.
Objective: The goal of the research was to determine the availability, functionality, and quality of mobile apps that could be
used for blood pressure monitoring purposes.
Methods: A systematic app search was performed based on the standards for systematic reviews. We searched the Dutch official
app stores for Android and iOS platforms using predefined keywords and included all English and Dutch mobile apps targeting
blood pressure. Two independent assessors determined eligibility and quality of the apps using the 5-point Mobile App Rating
Scale (MARS). Quality scores of the apps with and without 17 a priori selected characteristics were compared using independent
sample t tests.
Results: A total of 184 apps (104 Android, 80 iOS) met the inclusion criteria. The mean overall MARS score was 2.63 (95%
CI 2.55-2.71) for Android and 2.64 (95% CI 2.56-2.71) for iOS. The apps Bloeddruk (4.1) and AMICOMED BP (3.6) had the
highest quality scores on the Android and iOS platforms, respectively. Of the app characteristics recorded, only pricing, in-app
advertisements, and local data storage were not associated with the quality scores. In only 3.8% (7/184) of the apps, involvement
of medical experts in its development was mentioned, whereas none of the apps was formally evaluated with results published
in a peer-reviewed journal.
Conclusions: This study provides an overview of the best apps currently available in the app stores and important key features
for self-management that can be used by health care providers and patients with hypertension to identify a suitable app targeting
blood pressure monitoring. However, the majority of the apps targeting blood pressure monitoring were of poor quality. Therefore,
it is important to involve medical experts in the developmental stage of health-related mobile apps to improve the quality of these
apps.
(JMIR Mhealth Uhealth 2018;6(11):e187)   doi:10.2196/mhealth.9888
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Introduction
Hypertension contributes to the burden of various diseases
including heart disease [1] and leads to premature mortality and
morbidity [2]. Globally, 1 in 5 adults has hypertension [3], and
12.8% of total deaths worldwide are caused by high blood
pressure [4]. Hypertension is a chronic disease that may result
in severe complications such as stroke [5,6] and chronic kidney
disease [7,8]. High blood pressure is treated in the long term
pharmacologically and/or through lifestyle adjustments [9,10].
Therefore, continuous preventive care and daily management
of patients is important in controlling blood pressure.
Self-measured blood pressure monitoring leads to better blood
pressure control [11] and enhances medication adherence
[12,13]. In addition, self-measured blood pressure eliminates
white coat hypertension and can be useful in the detection of
masked hypertension [14].
The ownership of mobile phones is increasing rapidly and by
the end of 2017, over one-third of consumers worldwide owned
a mobile phone [15,16]. The health app market is growing and
thousands of new health apps are published every year. In 2016,
approximately 100,000 new health-related apps were published,
resulting in a total of 259,000 health apps currently available
in the major app stores [17]. The health app download rates
were estimated to reach 3.2 billion in 2016, an increase of 7%
compared to 2015 [17]. The main target areas of app developers
are chronic diseases such as hypertension and diabetes [17]. A
survey performed by Accenture showed that the use of health
apps and wearables increased by almost 50% among consumers
in 2016 compared to 2014 [18]. Furthermore, patients and
physicians agree about the potential benefits of health apps and
wearables [18].
Using a mobile app for self-management purposes could make
it easier for patients with hypertension to have insight into and
control their blood pressure. These apps may have several useful
features: logbook or diary features facilitate logging of blood
pressure measurements in an organized way, while reminder
functions could facilitate monitoring and medication adherence.
In addition, health apps may provide valuable background
information for patients about the disease, its treatment, how to
measure blood pressure adequately, and lifestyle management.
Analysis tools (eg, graphs and trend analysis) may provide an
overview of the course of blood pressure over time. Furthermore,
some apps can export blood pressure readings and other user
data to be sent by email. This enables patients to share their
measurements with their health care providers and relatives.
Although mobile apps have the potential to be beneficial for
patients with hypertension, little is known about the availability,
quality, and features of mobile apps targeting blood pressure.
Therefore, the aim of this study was to perform a systematic
review of apps to determine the availability, functionality, and
quality of mobile apps that could be used to collect readings of
blood pressure for monitoring purposes.
Methods
App Search and Selection
We performed a systematic app search based on the standards
for systematic reviews. Although we followed the standards for
systematic reviews of scientific literature, these guidelines are
not completely applicable to app reviews. All apps available in
the Google Play store for Android and iOS App Store targeting
blood pressure monitoring in which blood pressure
measurements could be entered manually were potentially
eligible for inclusion. On March 1, 2016, the Dutch app stores
were searched using the following search terms: blood pressure,
diastolic, health, heart rate, hypertension, hypotension, pressure,
systolic, and their Dutch equivalents (bloeddruk, diastole,
gezondheid, hartslag, hypertensie, hypotensie, and systole).
Apps in languages other than English or Dutch and duplicates
and irrelevant apps, such as games, were excluded. Some apps
had a free version and a pro version. In cases where there was
no difference in the functionality and relevant features between
the two versions, only the free version was included in this app
review. Two independent assessors (HJ and FRdG) selected the
eligible apps based on app titles, description of the app in the
app store, and screenshots provided. Discrepancies were
discussed until a final decision was reached.
Data Extraction
The selected apps were downloaded on either a Samsung Galaxy
S6 (Android version 6.0.1) or an iPhone 5c (iOS version 9.3.5)
for complete assessment of eligibility and characteristics. Two
independent assessors (HJ and LCHL) tested each app on each
platform in duplicate for a minimum of 10 minutes before
performing the final assessment. Using a standardized form,
the assessors recorded technical app information and app
features. Recorded technical information included the name of
the app, app developer, version number, platform, affiliations
of the app developers, price, number of ratings of all versions
in the app store, star ratings in app store, whether Web access
was required, data storage location (local and/or cloud), and
whether the app was free of advertisements. App features
included the ability of the app to register age, gender, height,
weight, time, and date of blood pressure reading, measurement
site (eg, left or right arm), and measurement position (eg, sitting
or standing). We also registered the presence of a reminder
function, analysis functions, data export, wireless transfer of
measurement data from a blood pressure monitor, and whether
user data were password-protected. Based on national and
international guidelines for the management of hypertension
[9,19-24] and recommendations from the literature addressing
the management of hypertension [25-28], we selected 6 key app
features that are essential for self-management. The key features
included the ability to export data, send reminders, analyze data,
record time and date of blood pressure reading, record weight,
and provide information/education. In addition, we searched
the app descriptions in the app stores for the involvement of
medical experts in the development of the app. Furthermore,
we searched PubMed and Google Scholar in March 2017 to
determine whether the apps were trialed or evaluated with results
published in peer-reviewed journals.
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App Quality Rating
The quality of the apps was evaluated using a standard
assessment protocol based on the Mobile App Rating Scale
(MARS) [29], a questionnaire that measures app quality using
23 questions divided into 4 objective categories (engagement,
functionality, aesthetics, and information quality) and 1
subjective category. Each question was rated on a 5-point scale
(1-inadequate, 2-poor, 3-acceptable, 4-good, 5-excellent). The
MARS overall score was calculated by averaging the means of
the 4 objective categories. The developers of MARS recommend
a training to standardize the assessors’ ratings [29], so the
assessors watched the MARS training video available on
YouTube [29]. Afterwards 10 randomly selected apps were
used for training purposes. The assessors discussed each item
of the MARS scale and reached consensus on the scores during
the training. After these 10 apps, the assessors did not discuss
any apps and rated them independently.
Statistical Analysis
We calculated the scores of the MARS separately per assessor
and averaged the scores at total level. The distributions of the
scores were checked for normality. We measured the interrater
reliability of the MARS scores using the intraclass correlation
coefficient (ICC). Based on the ICC guidelines developed by
Shrout and Fleiss [30], we used a 2-way mixed effects, average
measures model with a consistency of agreement definition
[31]. Cronbach alpha was used to assess the internal consistency
reliability (ie, the extent to which all items in a scale measure
the same concept) of the MARS [32].
Descriptive statistics were used to summarize and evaluate the
app features. Differences in proportions were tested using
chi-square tests. To determine whether specific characteristics
were associated with quality scores, MARS scores of apps with
and without the a priori selected characteristics were compared
using independent sample t tests. Pearson correlation coefficients
were calculated to compare the MARS overall scores with star
ratings obtained from the app stores of Android and iOS. Only
apps with 10 or more user ratings were included in this analysis.
Statistical significance was set at P<.05. The data were analyzed
using SPSS Statistics version 22 (IBM Corp).
Results
App Selection
A total of 4613 apps were identified using the search terms.
Screening on app titles and descriptions in the app stores resulted
in 276 potentially eligible apps. Further assessment, performed
after downloading and testing of the selected apps, resulted in
the inclusion of 184 apps, of which 104 were Android apps and
80 iOS apps. Some apps were available on both platforms so
were included twice in this study. Figure 1 illustrates the
selection procedure.
Figure 1. Flow diagram of the review and selection process.
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App Characteristics
The app characteristics are summarized in Table 1. The majority
of the apps included (77.7%, 143/184) were free of charge.
Android apps were more often free compared to iOS apps
(89.4% [93/104] vs 62.5% [50/80], P<.001). However, iOS
apps were more often free of advertisements compared to
Android apps (80.0% [40/50] vs 59.1% [55/93], P=.01). Less
than half of the apps tracked personal background data, with
the exception of weight tracking in Android apps. Only a small
proportion of apps recorded how the blood pressure
measurements were performed (measurement side, 15.2%,
28/184; position, 14.1%, 26/184). Compared to iOS apps,
Android apps more often recorded measurement side (20.2%
[21/104] vs 8.8% [7/80], P=.03) and position (19.2% [20/104]
vs 7.5% [6/80], P=.02). Only 2 apps did not register time and
date of the measurement. A reminder function was present in
28.8% (53/184) of apps, and data export was possible in 65.2%
(120/184) of apps. The latter was more often available in iOS
apps than in Android apps (75.0% [60/80] vs 57.7% [60/104],
P=.02). A total of 26 apps, of which 15 were Android and 11
iOS, contained 5 predefined key features. None of the apps
contained the key feature information/education.
A total of 182 apps were developed by commercial (31) or
unknown (151) developers. Only 2 apps (Heartkeeper and Blood
pressure monitoring for pregnancy) were developed by
universities or nongovernmental organizations. Of all apps
included, only 3.8% (7/184 ) stated the involvement of medical
experts in the development of the app in their own app store
description. None of the apps was trialed or evaluated with
results published in a peer-reviewed journal.
App Quality
The MARS overall and subscale scores were normally
distributed. For iOS apps, the overall interrater reliability of the
MARS was fair (ICC=0.42, 95% CI 0.21-0.59) and the Cronbach
alpha was 0.59. For Android apps, the interrater reliability was
slightly higher (ICC= 0.53, 95% CI 0.38-0.66) and the Cronbach
alpha was 0.70. Table 2 shows the ICCs and MARS scores for
the 5 categories and the MARS overall score per platform.
Table 1. Summary of characteristics of included apps, stratified by platform.
P valuesiOS (n=80), n (%)Android (n=104), n (%)All apps (n=184), n (%)Characteristics
Pricing
<.00150 (62.5)92 (89.4)143 (77.7)Free
.0140 (80.0)55 (59.1)95 (66.4)No advertisementsa
Personal data
.9133 (41.3)42 (40.4)75 (40.8)Age
.6734 (42.5)41 (39.4)75 (40.8)Gender
.2427 (33.7)44 (42.3)71 (38.6)Height
.0737 (46.2)62 (59.6)99 (53.8)Weightb
Blood pressure measurements
.037 (8.8)21 (20.2)28 (15.2)Side (left or right arm)
.026 (7.5)20 (19.2)26 (14.1)Position (eg, sitting, lying)
.8579 (98.8)103 (99.0)182 (98.9)Date and timeb
Other features
.9923 (28.7)30 (28.8)53 (28.8)Reminder functionb
.2566 (82.5)92 (88.5)158 (85.9)Analysis toolb
.0260 (75.0)60 (57.7)120 (65.2)Data exportb
.1715 (18.7)12 (11.5)27 (14.7)Data upload from blood pressure meter
.122 (2.5)8 (7.7)10 (5.4)Needs Web access to function
.1323 (28.7)20 (19.2)43 (23.4)Password protection
.7279 (98.8)102 (98.1)181 (98.4)Data storage (local)
.044 (5.0)15 (14.4)19 (10.3)Data storage (cloud)
aOnly free apps included; paid apps were presumed to have no advertisements.
bKey app features for self-management based on guidelines and literature.
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Table 2. Mobile App Rating Scale scores.
iOSAndroidMARSa subscale
AlphaICC (95% CI)Mean (95% CI)AlphacICCb (95% CI)Mean (95% CI)
.64.47 (.28-.63)2.26 (2.16-2.36).76.62 (.48-.72)2.28 (2.17-2.39)Engagement
.51.35 (.13-.53)3.55 (3.46-3.65).37.23 (.03-.41)3.54 (3.46-3.62)Functionality
.33.20 (.03-.40)3.16 (3.07-3.25).68.51 (.35-.64)3.06 (2.96-3.17)Aesthetics
.70.54 (.35-.68)1.57 (1.46-1.68).73.57 (.42-.69)1.63 (.52-1.73)Information
.65.49 (.29-.64)2.63 (2.42-2.84).72.56 (.41-.68)2.54 (2.35-2.74)Subjective quality
.59.42 (.21-.59)2.64 (2.56-2.71).70.53 (.38-.66)2.63 (2.55-2.71)MARS overall scored
aMARS: Mobile App Rating Scale.
bICC: intraclass correlation coefficient.
cAlpha: Cronbach alpha.
dAverage of 4 objective subscales.
Table 3. Quality scores comparison of apps with and without a specific characteristic.
DifferenceNot presentPresentCharacteristics
Mean (95% CI)Mean (SD)n (%)Mean (SD)n (%)
Pricing
.11 (–.24 to .02)2.55 (.33)41 (22.3)2.66 (.38)143 (77.7)Free
.03 (.10 to .16)2.64 (.37)48 (33.6)2.67 (.38)95 (66.4)No advertisementsa
Personal data
.25 (.15 to .35)2.53 (.32)109 (59.2)2.78 (.39)75(40.8)Age
.22 (.11 to .32)2.54 (.35)109 (59.2)2.76 (.36)75 (40.8)Gender
.18 (.07 to .28)2.56 (.37)113 (61.4)2.74 (.35)71 (38.6)Height
.24 (.14 to .34)2.50 (.33)85 (46.2)2.74 (.37)99 (53.8)Weightb
Blood pressure measurements
.23 (.09 to .38)2.60 (.35)156 (84.8)2.83 (.40)28 (15.2)Side (left or right arm)
.27 (.12 to .42)2.60 (.35)158 (85.9)2.87 (.42)26 (14.1)Position (eg, sitting, lying)
.60 (.08 to 1.01)2.04 (.61)2 (1.1)2.64 (.36)182 (98.9)Date and timeb
Other features
.26 (.15 to .38)2.56 (.35)131 (71.2)2.82 (.36)53 (28.8)Reminder functionb
.27 (.12 to .42)2.40 (.26)26 (14.1)2.67 (.37)158 (85.9)Analysis toolb
.23 (.13 to .35)2.48 (.28)64 (34.8)2.71 (.39)120 (65.2)Data exportb
.36 (.22 to. 51)2.58 (.35)157 (85.3)2.94 (.35)27 (14.7)Data upload from blood pressure meter
.26 (.03 to .50)2.62 (.36)174 (94.6)2.88 (.40)10 (5.4)Needs Web access to function
.19 (.07 to .32)2.59 (.38)141 (76.6)2.78 (.38)43 (23.4)Password protection
–.48 (–.89 to –.05)3.10 (.52)3 (1.6)2.62 (.36)181 (98.4)Data storage (local)
.46 (.29 to .62)2.58 (.33)165 (89.7)3.04 (.46)19 (10.3)Data storage (cloud)
aOnly free apps included; paid apps were presumed to have no advertisements.
bKey app features for self-management based on guidelines and literature.
On a scale from 1 to 5, the mean MARS score for the 4 objective
categories was 2.6 for both platforms. The MARS scores for
the separate categories were also very similar for Android and
iOS. Subjective quality scored 2.5 and 2.6 for Android and iOS,
respectively. Of the 5 categories, functionality received the
highest score (Android 3.5, iOS 3.6) and information the lowest
(Android 1.6, iOS 1.6). The complete list is available in
Multimedia Appendix 1.
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Among the 80 iOS apps, 7 had 10 or more user ratings in the
app store, but we did not observe a correlation between the star
ratings and the MARS overall score (r=0.29; P=.53). For
Android, 78 apps received ≥10 user ratings; these were not
correlated with the MARS scores either (r=0.17; P=.15). Table
3 shows the quality scores comparison for apps with and without
each characteristic. Incorporation of all characteristics resulted
in higher quality scores except for pricing, in-app
advertisements, and local data storage.
App Top 5
The 5 apps with the highest MARS overall scores per platform
are listed in Multimedia Appendix 2 together with their
characteristics. On Android, Bloeddruk (developer:
Klimaszewski Szymon) and Beurer HealthManager (developer:
Beurer) were the best-scoring apps, with MARS overall scores
of 4.1 and 3.7, respectively. AMICOMED BP (developer:
AMICOMED) was the best-scoring app on the iOS platform
with an overall score of 3.6. All apps in the top 5 for each
platform were free.
Discussion
Principal Findings
In this study, we observed a lower MARS overall score
compared to other reviews focusing on apps for other
self-management aspects [33-35]. However, comparable to our
study, functionality was previously reported as the objective
category with the highest MARS score [33,35]. Our results also
showed that some of the app features have a large influence on
the overall quality score. The app features with the most positive
influence on the app quality score are the ability of using the
cloud for data storage, wireless data upload from blood pressure
meters, ability to export data, ability to analyze data, ability to
send reminders, and ability to record personal data, such as age
and weight. More than half of the apps can export data and
approximately 15% of the apps were able to upload data from
blood pressure meters. If present, the latter feature makes it
easier and more convenient to measure and record blood
pressure.
Only approximately a quarter of the apps in our study had a
reminder function, but reminder features can be very important
in facilitating adherence [36,37]. The authors of a previous study
on hypertension apps reported similar results [38]. All of the
selected key features except information/education resulted in
a large positive influence on the app overall quality score. The
information/education feature was often absent or of poor quality
in the apps included in this study. Only 2 apps were developed
by a university or nongovernmental organizations and none of
the apps was evaluated with results published in the literature.
This, combined with the low scores for information on the
MARS scale, suggests the lack of involvement from medical
experts in the process of app development, which was also
reported in previous studies [39-42]. The high MARS scores
for functionality combined with the low MARS scores for
information suggests that most apps function well but lack
important information. This lack of information may result into
incorrect use of the app (eg, incorrect interpretation of blood
pressure readings, resulting in potential nonadherence to therapy)
by users who are not sufficiently literate in digital health.
Therefore, health apps should be validated before use. We found
suboptimal ICCs and Cronbach alphas for the functionality
subscale in Android and the aesthetics subscale in iOS. An
explanation for the suboptimal ICCs and Cronbach alphas may
be a lower agreement between assessors for the functionality
and aesthetics subscales due to discrepancies on subjective
criteria between the assessors, which arose after the training
used to standardize the assessors’ ratings. Another explanation
may be that the MARS is not a perfect instrument to assess these
features. The developers of MARS also reported a lower ICC
for the functionality subscale [29].
There were no differences in quality scores between paid and
free apps, which has also been reported previously [35]. Notably,
the top 5 apps, identified by the highest MARS overall scores,
were all free of charge. However, developers may earn money
with their apps by selling the data shared by users and/or by
promoting other products that can be combined with their apps,
such as blood pressure meters. PatientsLikeMe is a well-known
example. This platform is free of charge and very useful, but
user data is sold [43]. That may explain why these apps are
offered free of charge in the app stores by the app developers.
We did not observe a correlation between the star ratings and
the MARS overall scores. However, it is difficult to assess
reliability of star ratings in app stores, since the criteria and
qualifications of assessors are not always clear. For example,
reviewers may leave ratings that do not reflect their true opinions
or only selected users leave a rating (selection bias). The authors
of a recent study on app store user ratings and reviews of a blood
pressure app (Instant Blood Pressure) reported that these types
of ratings were unreliable [44].
In this study, we identified a large number of apps ineligible
for self-management and many apps of poor quality. These apps
may potentially be harmful to users. Apps providing patients
with erroneous information or apps that do not do what they are
supposed to do are examples of such harmful apps. At the
American Medical Association interim meeting in 2016,
Executive Vice President James Madara mentioned a blood
pressure app that failed at high rates in detecting elevated blood
pressure and yet was one of the most frequently downloaded
health apps for 2 years [45]. It is important to separate good
apps from the harmful ones and to stimulate the development
of high quality apps. Performing systematic app reviews and/or
developing guidelines for health app developers could reduce
the development of poor-quality health apps. It is important to
regulate the development of health apps internationally, because
apps are available in multiple national app stores. Therefore,
setting up an international institute to regulate the development
of health apps or certifying health apps may be necessary. The
Health On the Net Foundation (HON) is a good example of
such an institute. HON assesses the quality of health information
online and provides certification to websites with reliable health
information [46].
Strengths and Limitations
A major strength of this study is that we searched the 2 main
app stores systematically using 15 search terms in English and
Dutch and included both paid and free apps. This resulted in a
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large number of apps that were first screened on titles and
descriptions in the app stores. All apps identified through this
process were assessed by 2 independent reviewers. In addition,
we assessed the quality of the apps objectively using MARS
[29], which has previously been used to evaluate app quality in
several app reviews [35,47,48].
This review was limited to Dutch app stores, and we included
apps in English or Dutch only. It is possible that other national
app stores may contain a larger, smaller, or different assortment
of apps. Although it is not feasible to search all national app
stores from a single country, most apps are released worldwide
and are not country-specific. Furthermore, we limited our search
to the major app platforms Android and iOS. These platforms,
however, accounted for approximately 98% of the mobile phone
market share in 2015 [49]. In addition, we excluded apps that
need a prescription by a health care provider or permission for
use from the developer. Therefore, we may have missed
potentially eligible apps, but these are not generally available
to the target population. Another limitation was the compatibility
of apps. As a large variety of mobile phones with several
software versions are available in the markets, some apps may
not have been compatible with the devices used in this study.
However, it is not feasible to assess all apps using a large
spectrum of mobile phones. We used the most recent software
versions to ensure the maximum stability and safety.
Perspectives
Mobile apps may be a useful tool for self-management for
patients with hypertension. In addition, mobile apps could be
used to provide information to patients and increase awareness
about blood pressure–related health issues among patients. Also,
many mobile apps can export blood pressure data, which could
be used by health care providers to make more informed
decisions regarding treatment [50,51]. Furthermore, patients
will be more involved in their own treatment through the use
of high-quality, dedicated mobile apps. Therefore, health care
providers should stimulate the use of mobile apps by patients
with hypertension. In that case, however, they have to be sure
that the apps used by their patients do not contain any misleading
or harmful information. App reviews could be a suitable
instrument to separate the useful apps from the harmful ones.
Nevertheless, a practical guideline for app reviews is not
available. Therefore, it is crucial to develop an international
guideline for performing app reviews. This study provides a list
of the top 5 useable apps targeting blood pressure monitoring
available on the 2 major mobile phone platforms. Health care
providers and patients with hypertension can use the results
presented in this study to identify a suitable high-quality app
targeting blood pressure monitoring, provided that blood
pressure measurements are valid.
Conclusion
In this review, we identified only a few apps with sufficient
quality for blood pressure self-management purposes. The use
of these sufficient quality apps should be stimulated to improve
patient care. This study provides an overview of the best apps
currently available in the app stores and important key features
for self-management that can be used by health care providers
and patients with hypertension to identify a suitable app
targeting blood pressure monitoring. However, the majority of
the apps targeting blood pressure monitoring were of poor
quality, and the accuracy of the blood pressure measurements
registered in the apps was not assessed. It is important to involve
medical experts in the developmental stage of health-related
mobile apps to improve the quality of these apps.
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